Skip to main content
. 2021 Aug 27;203:564–574. doi: 10.1016/j.ymeth.2021.08.007

Table 9.

Mapping of CDK1 and NTRK1, EGFR with COVID-19 symptoms, risk factors and clinical outcomes.

Drug Key Target Genes Level COVID-19 symptoms Clinical outcome (Severe case) Risk Factor
Fostamatinib CDK1 Level-1 pneumonia diabetes
cancer
NTRK1 Level-2 fever kidney disease
cancer
hypertension
pneumonia lung disease
diabetes
EGFR Level-2 pneumonia neutrophilia heart disease
hypertension
cancer
dyspnea kidney disease
fever kidney injury lung disease
cough thrombocytopenia diabetes